Login to Your Account



Genaissance, Diagnostics Firm Plan To Merge In $56M Deal

By Randall Osborne


Wednesday, June 22, 2005
In a bid to fuse diagnostics with pharmacogenomics, Clinical Data Inc. is taking over Genaissance Pharmaceuticals Inc. in an all-stock deal valued at about $56 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription